US Stock MarketDetailed Quotes

VKTX Viking Therapeutics

Watchlist

62.260
+0.480+0.78%

Close May 31 16:00 ET

62.190
-0.070-0.11%

Post 19:55 ET

6.87BMarket Cap-67673P/E (TTM)

Viking Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

75.11%-6.13M

-51.61%-73.38M

-61.45%-17.64M

-45.63%-19.66M

14.93%-11.44M

-134.03%-24.64M

-1.70%-48.4M

11.53%-10.93M

-23.55%-13.5M

-0.06%-13.44M

Net income from continuing operations

-40.06%-27.36M

-24.73%-85.9M

-25.80%-24.61M

-42.86%-22.53M

-10.29%-19.23M

-21.29%-19.53M

-25.24%-68.87M

-58.30%-19.56M

-19.10%-15.77M

-13.33%-17.43M

Operating gains losses

----

--0

----

Depreciation and amortization

2.78%74K

0.34%292K

2.78%74K

-48.59%73K

--73K

-6.49%72K

-1.69%291K

-5.26%72K

89.33%142K

--0

Other non cash items

-7.50%37K

31.00%131K

80.00%36K

-76.92%12K

258.33%43K

150.00%40K

244.83%100K

66.67%20K

257.58%52K

-50.00%12K

Change In working capital

289.80%15.95M

-65.18%3.55M

-15.48%5.48M

48,600.00%1.46M

298.73%5.02M

-442.60%-8.4M

448.10%10.19M

385.46%6.48M

98.99%-3K

284.60%1.26M

-Change in receivables

169.55%655K

-47.72%321K

-187.83%-101K

62.91%246K

-127.57%-67K

131.43%243K

-47.79%614K

-80.64%115K

1,472.73%151K

-67.98%243K

-Change in prepaid assets

177.41%1.75M

304.73%6.41M

95.95%-58K

66.83%1.37M

388.95%7.35M

-9,917.39%-2.26M

-340.23%-3.13M

-366.45%-1.43M

-34.37%823K

-82.76%-2.54M

-Change in payables and accrued expense

316.31%13.64M

-121.98%-2.83M

-27.38%5.72M

91.10%-77K

-162.58%-2.18M

-362.56%-6.3M

522.75%12.89M

418.94%7.88M

40.51%-865K

9,297.30%3.48M

-Change in other current liabilities

-3.53%-88K

-83.60%-347K

-3.57%-87K

22.32%-87K

-206.02%-88K

-11.84%-85K

44.74%-189K

2.33%-84K

-31.76%-112K

196.51%83K

Cash from discontinued investing activities

Operating cash flow

75.11%-6.13M

-51.61%-73.38M

-61.45%-17.64M

-45.63%-19.66M

14.93%-11.44M

-134.03%-24.64M

-1.70%-48.4M

11.53%-10.93M

-23.55%-13.5M

-0.06%-13.44M

Investing cash flow

Cash flow from continuing investing activities

-21,018.65%-459.79M

-427.08%-179.09M

392.19%35.73M

-146.61%-12.53M

-1,177.36%-204.48M

35.76%2.2M

44.24%54.75M

-73.51%7.26M

97.50%26.89M

433.15%18.98M

Net investment purchase and sale

-21,018.65%-459.79M

-427.08%-179.09M

392.19%35.73M

-146.61%-12.53M

-1,177.36%-204.48M

35.76%2.2M

44.24%54.75M

-73.51%7.26M

97.50%26.89M

433.15%18.98M

Cash from discontinued investing activities

Investing cash flow

-21,018.65%-459.79M

-427.08%-179.09M

392.19%35.73M

-146.61%-12.53M

-1,177.36%-204.48M

35.76%2.2M

44.24%54.75M

-73.51%7.26M

97.50%26.89M

433.15%18.98M

Financing cash flow

Cash flow from continuing financing activities

14,384.63%606.04M

6,418.76%271.38M

-98.25%188K

-840.00%-74K

16,897.36%267.08M

183.58%4.18M

-39.49%4.16M

22,770.21%10.75M

103.91%10K

-183.77%-1.59M

Net common stock issuance

1,613,935.14%597.12M

--0

-2,697,500.00%-269.76M

2,697,500.00%269.76M

102.21%37K

99.28%-37K

---6.8M

---10K

--10K

---1.67M

Proceeds from stock option exercised by employees

9.96%4.36M

698.11%6.77M

25.33%188K

---1K

3,013.10%2.62M

545.93%3.97M

-88.89%848K

127.27%150K

--0

-95.57%84K

Net other financing activities

1,687.06%4.56M

2,517.29%264.61M

2,442.75%269.76M

---269.83M

--264.43M

151.10%255K

1,442.63%10.11M

55,936.84%10.61M

--0

Cash from discontinued financing activities

Financing cash flow

14,384.63%606.04M

6,418.76%271.38M

-98.25%188K

-840.00%-74K

16,897.36%267.08M

183.58%4.18M

-39.49%4.16M

22,770.21%10.75M

103.91%10K

-183.77%-1.59M

Net cash flow

Beginning cash position

51.55%55.52M

38.91%36.63M

26.45%37.19M

328.44%69.52M

47.44%18.36M

38.91%36.63M

-9.43%26.37M

161.08%29.41M

83.78%16.23M

-25.89%12.45M

Current changes in cash

867.27%140.11M

79.81%18.91M

158.10%18.28M

-340.70%-32.27M

1,195.85%51.16M

-31.21%-18.26M

483.07%10.52M

-53.11%7.08M

450.51%13.41M

149.50%3.95M

Effect of exchange rate changes

-433.33%-48K

88.37%-30K

-64.54%50K

69.51%-68K

98.30%-3K

---9K

---258K

--141K

---223K

---176K

End cash Position

965.13%195.58M

51.55%55.52M

26.45%37.19M

328.44%69.52M

47.44%18.36M

38.91%36.63M

161.08%29.41M

83.78%16.23M

Free cash flow

75.11%-6.13M

-51.61%-73.38M

-61.45%-17.64M

-45.63%-19.66M

14.93%-11.44M

-134.03%-24.64M

-1.70%-48.4M

11.53%-10.93M

-23.55%-13.5M

-0.06%-13.44M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	75.11%-6.13M	-51.61%-73.38M	-61.45%-17.64M	-45.63%-19.66M	14.93%-11.44M	-134.03%-24.64M	-1.70%-48.4M	11.53%-10.93M	-23.55%-13.5M	-0.06%-13.44M
Net income from continuing operations	-40.06%-27.36M	-24.73%-85.9M	-25.80%-24.61M	-42.86%-22.53M	-10.29%-19.23M	-21.29%-19.53M	-25.24%-68.87M	-58.30%-19.56M	-19.10%-15.77M	-13.33%-17.43M
Operating gains losses	----	----	----	----	----	----	----	----	--0	----
Depreciation and amortization	2.78%74K	0.34%292K	2.78%74K	-48.59%73K	--73K	-6.49%72K	-1.69%291K	-5.26%72K	89.33%142K	--0
Other non cash items	-7.50%37K	31.00%131K	80.00%36K	-76.92%12K	258.33%43K	150.00%40K	244.83%100K	66.67%20K	257.58%52K	-50.00%12K
Change In working capital	289.80%15.95M	-65.18%3.55M	-15.48%5.48M	48,600.00%1.46M	298.73%5.02M	-442.60%-8.4M	448.10%10.19M	385.46%6.48M	98.99%-3K	284.60%1.26M
-Change in receivables	169.55%655K	-47.72%321K	-187.83%-101K	62.91%246K	-127.57%-67K	131.43%243K	-47.79%614K	-80.64%115K	1,472.73%151K	-67.98%243K
-Change in prepaid assets	177.41%1.75M	304.73%6.41M	95.95%-58K	66.83%1.37M	388.95%7.35M	-9,917.39%-2.26M	-340.23%-3.13M	-366.45%-1.43M	-34.37%823K	-82.76%-2.54M
-Change in payables and accrued expense	316.31%13.64M	-121.98%-2.83M	-27.38%5.72M	91.10%-77K	-162.58%-2.18M	-362.56%-6.3M	522.75%12.89M	418.94%7.88M	40.51%-865K	9,297.30%3.48M
-Change in other current liabilities	-3.53%-88K	-83.60%-347K	-3.57%-87K	22.32%-87K	-206.02%-88K	-11.84%-85K	44.74%-189K	2.33%-84K	-31.76%-112K	196.51%83K
Cash from discontinued investing activities
Operating cash flow	75.11%-6.13M	-51.61%-73.38M	-61.45%-17.64M	-45.63%-19.66M	14.93%-11.44M	-134.03%-24.64M	-1.70%-48.4M	11.53%-10.93M	-23.55%-13.5M	-0.06%-13.44M
Investing cash flow
Cash flow from continuing investing activities	-21,018.65%-459.79M	-427.08%-179.09M	392.19%35.73M	-146.61%-12.53M	-1,177.36%-204.48M	35.76%2.2M	44.24%54.75M	-73.51%7.26M	97.50%26.89M	433.15%18.98M
Net investment purchase and sale	-21,018.65%-459.79M	-427.08%-179.09M	392.19%35.73M	-146.61%-12.53M	-1,177.36%-204.48M	35.76%2.2M	44.24%54.75M	-73.51%7.26M	97.50%26.89M	433.15%18.98M
Cash from discontinued investing activities
Investing cash flow	-21,018.65%-459.79M	-427.08%-179.09M	392.19%35.73M	-146.61%-12.53M	-1,177.36%-204.48M	35.76%2.2M	44.24%54.75M	-73.51%7.26M	97.50%26.89M	433.15%18.98M
Financing cash flow
Cash flow from continuing financing activities	14,384.63%606.04M	6,418.76%271.38M	-98.25%188K	-840.00%-74K	16,897.36%267.08M	183.58%4.18M	-39.49%4.16M	22,770.21%10.75M	103.91%10K	-183.77%-1.59M
Net common stock issuance	1,613,935.14%597.12M	--0	-2,697,500.00%-269.76M	2,697,500.00%269.76M	102.21%37K	99.28%-37K	---6.8M	---10K	--10K	---1.67M
Proceeds from stock option exercised by employees	9.96%4.36M	698.11%6.77M	25.33%188K	---1K	3,013.10%2.62M	545.93%3.97M	-88.89%848K	127.27%150K	--0	-95.57%84K
Net other financing activities	1,687.06%4.56M	2,517.29%264.61M	2,442.75%269.76M	---269.83M	--264.43M	151.10%255K	1,442.63%10.11M	55,936.84%10.61M	--0	--0
Cash from discontinued financing activities
Financing cash flow	14,384.63%606.04M	6,418.76%271.38M	-98.25%188K	-840.00%-74K	16,897.36%267.08M	183.58%4.18M	-39.49%4.16M	22,770.21%10.75M	103.91%10K	-183.77%-1.59M
Net cash flow
Beginning cash position	51.55%55.52M	38.91%36.63M	26.45%37.19M	328.44%69.52M	47.44%18.36M	38.91%36.63M	-9.43%26.37M	161.08%29.41M	83.78%16.23M	-25.89%12.45M
Current changes in cash	867.27%140.11M	79.81%18.91M	158.10%18.28M	-340.70%-32.27M	1,195.85%51.16M	-31.21%-18.26M	483.07%10.52M	-53.11%7.08M	450.51%13.41M	149.50%3.95M
Effect of exchange rate changes	-433.33%-48K	88.37%-30K	-64.54%50K	69.51%-68K	98.30%-3K	---9K	---258K	--141K	---223K	---176K
End cash Position	965.13%195.58M	51.55%55.52M	51.55%55.52M	26.45%37.19M	328.44%69.52M	47.44%18.36M	38.91%36.63M	38.91%36.63M	161.08%29.41M	83.78%16.23M
Free cash flow	75.11%-6.13M	-51.61%-73.38M	-61.45%-17.64M	-45.63%-19.66M	14.93%-11.44M	-134.03%-24.64M	-1.70%-48.4M	11.53%-10.93M	-23.55%-13.5M	-0.06%-13.44M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Overall